Michael Zinda

EVP & Chief Scientific Officer at Repare Therapeutics

Michael Zinda, Ph.D. has served as their Executive Vice President, Chief Scientific Officer since May 2019 and previously served as Executive Vice President, Head of Research and Development of their U.S. subsidiary, Repare Therapeutics USA Inc., from June 2017 to May 2019. Prior to joining us, he spent 16 years at AstraZeneca from 2001 to May 2017, where he obtained the position of Executive Director, Head of Cancer Bioscience.

In this role, Dr. Zinda served on the global science leadership team, oncology research board and the Acerta research and early development teams accountable for strategy, key collaborations/partnerships and delivery of an innovative portfolio of patient-centric drug discovery programs.

Dr. Zinda holds a B.Sc. in biology from Minnesota State University Moorhead and a Ph.D. in molecular biology from Vanderbilt University. He received his post-doctoral training at Princeton University and Eli Lilly & Company.

Location

Waltham, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Repare Therapeutics

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.


Employees

11-50

Links